CNBC: Novo beats on Wegovy and Ozempic sales
CNBC reports Q3 sales of DKK 79.2bn against expectations of about DKK 73.6bn, with injectable Wegovy at DKK 20.4bn and Ozempic at DKK 29.7bn, both above estimates. Novo is trying to regain ground lost to Lilly over the past year.
Source: CNBC (4 Nov 2026). Image: CNBC.